126 related articles for article (PubMed ID: 2793391)
1. Safety and pharmacokinetics of ioversol in healthy volunteers.
Wilkins RA; Whittington JR; Brigden GS; Lahiri A; Heber ME; Hughes LO
Invest Radiol; 1989 Oct; 24(10):781-8. PubMed ID: 2793391
[TBL] [Abstract][Full Text] [Related]
2. Tolerability of iohexol after injection into healthy volunteers.
Levorstad K; Kolbenstvedt A; Kolmannskog F; Sommerfelt SC; Stormorken H; Andrew E; Sveen K
Acta Radiol Diagn (Stockh); 1983; 24(3):241-51. PubMed ID: 6624528
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic effects of iopentol after intravenous injection in healthy volunteers. Preliminary report.
Aakhus T; Stokke O; Stormorken H; Berg KJ; Dahlstrøm K
Acta Radiol Suppl; 1987; 370():109-12. PubMed ID: 2980303
[TBL] [Abstract][Full Text] [Related]
4. Thrombin generation in nonclottable mixtures of blood and nonionic contrast agents.
Kopko PM; Smith DC; Bull BS
Radiology; 1990 Feb; 174(2):459-61. PubMed ID: 2296655
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic and electrocardiographic effects of ioversol during cardiac angiography. Comparison with iopamidol and diatrizoate.
Hirshfeld JW; Wieland J; Davis CA; Giles BD; Passione D; Ray MB; Ripley NS
Invest Radiol; 1989 Feb; 24(2):138-44. PubMed ID: 2645244
[TBL] [Abstract][Full Text] [Related]
6. Tolerance and biochemical effects from intravenous injection of ioxaglate in healthy volunteers.
Nilsson PE; Aspelin P; Nyman U; Hedner U
Acta Radiol Diagn (Stockh); 1984; 25(6):523-8. PubMed ID: 6524437
[TBL] [Abstract][Full Text] [Related]
7. Cardiac and hemodynamic tolerability of iopromide with or without sodium or iloprost and of ioversol in the anesthetized rat.
Krause W; Muschick P; Wehrmann D
Invest Radiol; 1994 Nov; 29(11):978-84. PubMed ID: 7534283
[TBL] [Abstract][Full Text] [Related]
8. Ioversol in ascending phlebography--a clinical trial.
Scott H; Palmer FJ
Australas Radiol; 1990 Feb; 34(1):44-6. PubMed ID: 2192700
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic effects of ioversol in the dog and rat.
Ralston WH; Robbins MS; Coveney JR
Invest Radiol; 1989 Jun; 24 Suppl 1():S10-5. PubMed ID: 2592167
[TBL] [Abstract][Full Text] [Related]
10. Ioversol clinical safety summary.
Benamor M; Aten EM; McElvany KD; Lankin DG; James MA; Buy-Gandal T; Harashe LT; Weinandt WJ
Invest Radiol; 1989 Jun; 24 Suppl 1():S67-72. PubMed ID: 2687200
[TBL] [Abstract][Full Text] [Related]
11. [Effects of intravenous injection of ioversol, a nonionic contrast medium, on circulating blood volume: comparison among different combinations of its dose and volume injected].
Sakuma I; Sakuma K; Fukao M; Akaishi Y; Asajima H; Sato M; Shudo H; Numazawa K; Kakinoki S; Kitabatake A
Kokyu To Junkan; 1993 Dec; 41(12):1191-5. PubMed ID: 8284543
[TBL] [Abstract][Full Text] [Related]
12. Computed body tomography with a new nonionic contrast agent. Comparison of ioversol with sodium/meglumine diatrizoate.
McClennan BL; Heiken JP; Lee JK; James MA
Invest Radiol; 1989 Jun; 24 Suppl 1():S35-8. PubMed ID: 2687193
[TBL] [Abstract][Full Text] [Related]
13. Safety and toleration of the non-ionic contrast medium iopentol. An intravenous phase I trial.
Jakobsen JA; Hagve TA; Holager T; Waaler A; Haider T; Andrew E; Aakhus T
Eur J Radiol; 1989 Nov; 9(4):203-7. PubMed ID: 2591384
[TBL] [Abstract][Full Text] [Related]
14. Ioversol for intravenous urography: a comparison study.
Kaufman AJ; Concepcion R; Kirchner FK; McDougal WS; Winfield AC
Urol Radiol; 1990; 12(1):56-60. PubMed ID: 2333674
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of iotrolan after intravenous injection into healthy volunteers.
Scholz P; Weinmann HJ; Mützel W; Staks T
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():211-4. PubMed ID: 2568798
[TBL] [Abstract][Full Text] [Related]
16. Ascending lower limb phlebography: comparison of ioversol and iothalamate meglumine.
Wilson AJ; Murphy WA; Destouet JM; Gilula LA; Hardy DC; Monsees B; Totty WG
Can Assoc Radiol J; 1989 Jun; 40(3):142-4. PubMed ID: 2660958
[TBL] [Abstract][Full Text] [Related]
17. Ioversol. Double-blind study of a new low osmolar contrast agent for peripheral and visceral arteriography.
Grassi CJ; Bettmann MA; Finkelstein J; Reagan K
Invest Radiol; 1989 Feb; 24(2):133-7. PubMed ID: 2917833
[TBL] [Abstract][Full Text] [Related]
18. Renal effects of the non-ionic contrast medium iopentol after intravenous injection in healthy volunteers.
Jakobsen JA; Berg KJ; Waaler A; Andrew E
Acta Radiol; 1990 Jan; 31(1):87-91. PubMed ID: 2187515
[TBL] [Abstract][Full Text] [Related]
19. Comparative trial of iohexol 350, a non-ionic contrast medium, with diatrizoate (Urografin 370) in left ventriculography and coronary arteriography.
Sullivan ID; Wainwright RJ; Reidy JF; Sowton E
Br Heart J; 1984 Jun; 51(6):643-7. PubMed ID: 6375703
[TBL] [Abstract][Full Text] [Related]
20. Double-blind study of a new nonionic contrast agent for cardiac angiography.
Reagan K; Bettman MA; Finkelstein J; Ganz P; Grassi CJ
Radiology; 1988 May; 167(2):409-13. PubMed ID: 3282261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
